Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Seminars in Immunopathology
Literature
1.
Younger DS, Hays AP, Brust JC, Rowland LP (1988) Granulomatous angiitis of the brain. An inflammatory reaction of diverse etiology. Arch Neurol 45:514–518PubMed
2.
Watts RA, Scott DG (1997) Classification and epidemiology of the vasculitides. Baillieres. Clin Rheumatol 11:191–217
3.
Lie JT (1997) Classification and histopathologic spectrum of central nervous system vasculitis. Neurol Clin 15:805–819CrossRefPubMed
4.
Schmidley JW (2000) Central nervous system angiitis. Butterworth-Heinemann, Oxford
5.
Kolodny EH, Rebeiz JJ, Caviness VS Jr, Richardson EP Jr (1968) Granulomatous angiitis of the central nervous system. Arch Neurol 19:510–524PubMed
6.
7.
Salojin KV, Le TM, Nassovov EL, Blouch MT, Baranov AA, Saraux A, Guillevin L, Fiessinger JN, Piette JC, Youinou P (1996) Anti-endothelial cell antibodies in patients with various forms of vasculitis. Clin Exp Rheumatol 14:163–169PubMed
8.
Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, Mackenzie JM, Xuereb JH, Love S (2005) A{beta}-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128:500–515CrossRefPubMed
9.
Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L, Piette JC (2001) Systemic vasculitis in patients with hepatitis C. J Rheumatol 28:109–118PubMed
10.
Kallenberg CG, Heeringa P, Stegeman CA (2006) Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2:661–670CrossRefPubMed
11.
12.
Harper L, Williams JM, Savage CO (2004) The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis. Biochem Soc Trans 32:502–506CrossRefPubMed
13.
Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955–963PubMed
14.
15.
Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15:623–625CrossRefPubMed
16.
Mathieson PW, Oliveira DB (1995) The role of cellular immunity in systemic vasculitis. Clin Exp Immunol 100:183–185PubMed
17.
18.
Weyand CM, Ma-Krupa W, Goronzy JJ (2004) Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 3:46–53CrossRefPubMed
19.
Scolding NJ, Jayne DR, Zajicek JP, Meyer PAR, Wraight EP, Lockwood CM (1997) The syndrome of cerebral vasculitis: recognition, diagnosis and management. Q J Med 90:61–73
20.
Molloy ES, Singhal AB, Calabrese LH (2008) Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system. Ann Rheum Dis 67:1732–1735CrossRefPubMed
21.
Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33:4–9CrossRefPubMed
22.
Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefPubMed
23.
Sehgal M, Swanson JW, DeRemee RA, Colby TV (1995) Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 70:337–341CrossRefPubMed
24.
Scolding NJ (1999) Neurological complications of rheumatological and connective tissue disorders. In: Scolding NJ (ed) Immunological and Inflammatory diseases of the central nervous system. Butterworth-Heinemann, Oxford, pp 147–180
25.
Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A (2009) Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med 39:124–145CrossRefPubMed
26.
Zajicek JP, Scolding NJ, Foster O, Rovaris J, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis - diagnosis and management. Q J Med 92:103–117
27.
28.
Hilt DC, Buchholz D, Krumholz A, Weiss H, Wolinsky JS (1983) Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol 14:543–553CrossRefPubMed
29.
Citron BP, Halpern M, McCarron M, Lundberg GD, McCormick R, Pincus IJ, Tatter D, Haverback BJ (1970) Necrotizing angiitis associated with drug abuse. N Engl J Med 283:1003–1011PubMed
30.
Aggarwal SK, Williams V, Levine SR, Cassin BJ, Garcia JH (1996) Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology 46:1741–1743PubMed
31.
Scolding NJ (1999) Cerebral vasculitis. In: Scolding NJ (ed) Immunological and Inflammatory diseases of the central nervous system. Butterworth-Heinemann, Oxford, pp 210–258
32.
Calabrese LH, Mallek JA (1988) Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine 67:20–39CrossRefPubMed
33.
Hankey G (1991) Isolated angiitis/angiopathy of the CNS. Prospective diagnostic and therapeutic experience. Cerebrovasc Dis 1:2–15CrossRef
34.
Harris KG, Tran DD, Sickels WJ, Cornell SH, Yuh WTC (1994) Diagnosing intracranial vasculitis: the roles of MR and angiography. Am J Neuroradiol 15:317–330PubMed
35.
Cloft HJ, Phillips CD, Dix JE, McNulty BC, Zagardo MT, Kallmes DF (1999) Correlation of angiography and MR imaging in cerebral vasculitis. Acta Radiol 40:83–87PubMed
36.
Koennecke HC (2006) Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 66:165–171CrossRefPubMed
37.
Scolding N (2007) Can diffusion-weighted imaging improve the diagnosis of CNS vasculitis? Nat Clin Pract Neurol 3:608–609CrossRefPubMed
38.
Akin E, Coen A, Momeni M (2009) PET-CT findings in large vessel vasculitis presenting as FUO, a case report. Clin Rheumatol 28:737–738CrossRefPubMed
39.
Atalay MK, Bluemke DA (2001) Magnetic resonance imaging of large vessel vasculitis. Curr Opin Rheumatol 13:41–47CrossRefPubMed
40.
Alrawi A, Trobe J, Blaivas M, Musch DC (1999) Brain biopsy in primary angiitis of the central nervous system. Neurology 53:858–860PubMed
41.
Hellmann DB, Roubenoff R, Healy RA, Wang H (1992) Central nervous system angiography: safety and predictors of a positive result in 125 consecutive patients evaluated for possible vasculitis. J Rheumatol 19:568–572PubMed
42.
Scolding NJ, Wilson H, Hohlfeld R, Polman C, Leite I, Gilhus N (2002) The recognition, diagnosis and management of cerebral vasculitis: a European survey. Eur J Neurol 9:343–347CrossRefPubMed
43.
Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, De GK, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36–44CrossRefPubMed
44.
Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis [see comments]. Ann Intern Med 124:477–484PubMed
45.
Jayne DR, Chapel H, Adu D, Misbah S, O’Donoghue D, Scott D, Lockwood CM (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433–439CrossRefPubMed
46.
Gaskin G, Pusey CD (2001) Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Ther Apher 5:176–181CrossRefPubMed
47.
Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D (2004) Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 15:717–721CrossRefPubMed
48.
Unger L, Kayser M, Nusslein HG (2003) Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 62:587–588CrossRefPubMed
49.
Mathieson PW, Cobbold SP, Hale G, Clark MR, Oliveira DBG, Lockwood CM, Waldman H (1990) Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med 323:250–254PubMedCrossRef
50.
Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM (2004) Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 31:1955–1958PubMed
51.
Sneller MC (2005) Rituximab and Wegener’s granulomatosis: are B cells a target in vasculitis treatment? Arthritis Rheum 52:1–5CrossRefPubMed
Metadata
Title
Central nervous system vasculitis
Author
Neil J. Scolding
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Seminars in Immunopathology / Issue 4/2009
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-009-0183-2

Other articles of this Issue 4/2009

Seminars in Immunopathology 4/2009 Go to the issue

Review

Novel approaches for identifying target antigens of autoreactive human B and T cells

Introduction

Progress in understanding inflammatory and autoimmune diseases of the central nervous system

Review

Role of microglia in neuronal degeneration and regeneration

Review

Progressive multiple sclerosis

Review

Encephalitis and epilepsy

Review

The pathological spectrum of CNS inflammatory demyelinating diseases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits